Please provide your email address to receive an email when new articles are posted on . Patient-reported physical function predicts which patients gain greatest survival benefit from daratumumab.

Health-related quality of life (HRQoL) in children with interstitial lung disease (ILD) is strongly influenced by clinical and developmental factors such as recent hospitalizations and poor growth, ...